6-O-(E)-p-Hydroxy-cinnamoyl-glucose | 114297-65-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 6-O-(E)-p-Hydroxy-cinnamoyl-glucose
• 英文别名: [(2R,3R,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexyl] (E)-3-(4-hydroxyphenyl)prop-2-enoate
• CAS: 114297-65-3
• 化学式: C₁₅H₁₈O₈
• 分子量: 326.3
• InChiKey: NKAUYEOJVXZPIW-ZZPZHBAMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.1
• 重原子数：
  23
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  145
• 氢给体数：
  5
• 氢受体数：
  8

文献信息

• USE OF PTEROSIN COMPOUNDS FOR TREATING DIABETES AND OBESITY
  申请人：Taipei Medical University

  公开号：EP2389171B1

  公开（公告）日：2016-03-30
• PTEROSIN DERIVATIVE-CONTAINING THERAPEUTIC PREPARATION FOR DISEASE ASSOCIATED WITH CARTILAGE LOSS, CARTILAGE DEGENERATION AND/OR CARTILAGE THINNING
  申请人：KYOTO UNIVERSITY

  公开号：US20150051293A1

  公开（公告）日：2015-02-19

  An object of the present invention is to provide a therapeutic preparation and method for diseases associated with cartilage loss, cartilage degeneration and/or cartilage thinning. The present invention provides a therapeutic preparation comprising a pterosin derivative or a pharmaceutically acceptable salt thereof for diseases associated with cartilage loss, cartilage degeneration and/or cartilage thinning; and a therapeutic method for the diseases.
• US9668985B2
  申请人：——

  公开号：US9668985B2

  公开（公告）日：2017-06-06